Product
Betamethasone Sodium Phosphate
2 clinical trials
1 indication
Indication
Dry Eye SyndromeClinical trial
A Multicenter, Randomized, Double-Masked, Dose-Ranging Study To Compare The Ocular Safety, Tolerability, And Efficacy Of SURF-200 Ophthalmic Solution (0.02% And 0.04% Betamethasone Sodium Phosphate) To Vehicle In Subjects With A Diagnosis Of Dry Eye Disease And Experiencing An Episodic Flare UpStatus: Completed, Estimated PCD: 2022-10-12
Clinical trial
A Multicenter, Randomized, Double-Masked Study To Evaluate The Safety, Tolerability, And Efficacy Of SURF-100 Ophthalmic Solution (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination) In Subjects With Dry Eye DiseaseStatus: Completed, Estimated PCD: 2022-03-25